|
|
Alzheimer's Disease and Memantine Products |
| An animal model evaluation of the therapeutic use of memantine, and memantine and tacrine, for the treatment of Alzheimer's disease Catherine E. Creeley ProQuest / UMI ProQuest / UMI |
Sale Price: $69.99
|
| Pocket Pharma: Memantine and Alzheimer's Disease (Pocket Pharma) Bengt Winblad Science Press Science Press |
Sale Price: $15.95
|
| First drug for advanced Alzheimer's approved: NMDA antagonist memantine will be available in January.: An article from: Clinical Psychiatry News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Memantine can cut Alzheimer's-related costs. (FDA Approval Expected by Year-End).: An article from: Clinical Psychiatry News Norra MacReady International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| FDA panel approves memantine for moderate to severe Alzheimer's: NMDA receptor antagonist.(Rx): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Panel backs memantine for moderate, severe Alzheimer's: FDA approval likely this year.(News): An article from: Clinical Psychiatry News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Drug for severe Alzheimer's disease is heading to U.S. (10-plus Years' Experience in Germany).: An article from: Clinical Psychiatry News Miriam E. Tucker International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Alzheimer's disease.(DRUG UPDATE): An article from: Family Practice News Mitchel L. Zoler, Patrice Wendling International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| New option for moderate to severe Alzheimer's: memantine available in 2004.(Rx)(N-methyl-D-aspartate (NMDA) receptor antagonist ): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Memantine also effective in mild to moderate Alzheimer's disease.(Geriatric Psychiatry): An article from: Clinical Psychiatry News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Memantine shows efficacy for mild Alzheimer's disease.(Rx): An article from: Internal Medicine News Mitchel L. Zoler International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Memantine: a new approach to Alzheimer's disease.(Biological Perspectives): An article from: Perspectives in Psychiatric Care Norman L. Keltner, Beth Williams Nursecom, Inc. Nursecom, Inc. |
Sale Price: $5.95
|

Not Signed In - 


